» Articles » PMID: 31656683

Next-generation Care Pathways for Allergic Rhinitis and Asthma Multimorbidity: a Model for Multimorbid Non-communicable Diseases-Meeting Report (Part 2)

Citing Articles

EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR.

Scadding G, Conti D, Scheire S, Backer V, Blaiss M, Cardell L Front Allergy. 2025; 5:1531788.

PMID: 39963330 PMC: 11830706. DOI: 10.3389/falgy.2024.1531788.


The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy.

House R, Kritikos V, Cvetkovski B, Rimmer J, Yan K, Cheong L Explor Res Clin Soc Pharm. 2023; 12:100340.

PMID: 37869069 PMC: 10585337. DOI: 10.1016/j.rcsop.2023.100340.


Effectiveness of mobile health interventions to improve nasal corticosteroid adherence in allergic rhinitis: A systematic review.

Stage Baxter M, Tibble H, Bush A, Sheikh A, Schwarze J Clin Transl Allergy. 2021; 11(9):e12075.

PMID: 34841729 PMC: 9815425. DOI: 10.1002/clt2.12075.


Harmonizing allergy care-integrated care pathways and multidisciplinary approaches.

Daniels L, Barker S, Chang Y, Chikovani T, DunnGalvin A, Gerdts J World Allergy Organ J. 2021; 14(10):100584.

PMID: 34820045 PMC: 8591185. DOI: 10.1016/j.waojou.2021.100584.


Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report.

Bousquet J, Bedbrook A, Czarlewski W, De Carlo G, Fonseca J, Ballester M J Thorac Dis. 2021; 13(5):3215-3225.

PMID: 34164213 PMC: 8182538. DOI: 10.21037/jtd-21-792.


References
1.
Tai A, Tran H, Roberts M, Clarke N, Gibson A, Vidmar S . Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol. 2014; 133(6):1572-8.e3. DOI: 10.1016/j.jaci.2013.12.1033. View

2.
Brozek J, Akl E, Compalati E, Kreis J, Terracciano L, Fiocchi A . Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy. 2011; 66(5):588-95. DOI: 10.1111/j.1398-9995.2010.02530.x. View

3.
Bachert C, Bousquet J, Hellings P . Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin Transl Allergy. 2018; 8:25. PMC: 6016145. DOI: 10.1186/s13601-018-0210-2. View

4.
Fokkens W, Lund V, Mullol J, Bachert C, Alobid I, Baroody F . EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012; 50(1):1-12. DOI: 10.4193/Rhino12.000. View

5.
Hellings P, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C . European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy. 2018; 7:49. PMC: 5745781. DOI: 10.1186/s13601-017-0186-3. View